Banque Pictet & Cie Sa Tg Therapeutics, Inc. Transaction History
Banque Pictet & Cie Sa
- $12.3 Billion
- Q1 2025
A detailed history of Banque Pictet & Cie Sa transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 13,151 shares of TGTX stock, worth $576,802. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,151Holding current value
$576,802% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TGTX
# of Institutions
373Shares Held
85.7MCall Options Held
3.78MPut Options Held
3M-
Vanguard Group Inc Valley Forge, PA15.6MShares$684 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$499 Million0.0% of portfolio
-
State Street Corp Boston, MA9.2MShares$404 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.19MShares$140 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V82.79MShares$123 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $6.37B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...